Disease Library/Hereditary late-onset Parkinson disease/Advocacy Hub

Hereditary late-onset Parkinson disease

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database
💊
1FDA treatments
🩺
1Specialists
💰
1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Hereditary late-onset Parkinson disease.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Onapgo

MDD US Operations, LLC

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Onapgo

(apomorphine hydrochloride)Orphan drug

MDD US Operations, LLC

12.1 Mechanism of Action ONAPGO is a non-ergoline dopamine agonist with high in vitro binding affinity for the dopamine D4 receptor, and moderate affi...

Approved Feb 2025FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hereditary late-onset Parkinson disease.
Search all trials →
Search clinical trials for Hereditary late-onset Parkinson disease →

Recent News & Research

No recent news articles indexed yet for Hereditary late-onset Parkinson disease.
Search PubMed for Hereditary late-onset Parkinson disease →

Browse all Hereditary late-onset Parkinson disease news →

Specialist Network

Top 1 by expertise
LA

Laura Andres-Martin, PhD

New York Stem Cell Foundation Research Institute

Score 31 trial

View all Hereditary late-onset Parkinson disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰

Latest News

Research, approvals & updates

📚

Browse All Diseases

11,000+ rare disease profiles